| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6106848 | GALDERMA LABS LP | Topically applicable O/W emulsions having high glycol content and at least one biologically active agent |
Sep, 2017
(6 years ago) | |
| US5972920 | GALDERMA LABS LP | Formulation containing a carrier, active ingredient, and surfactant for treating skin disorders |
Feb, 2018
(6 years ago) | |
| US5990100 | GALDERMA LABS LP | Composition and method for treatment of psoriasis |
Mar, 2018
(6 years ago) | |
Clobex is owned by Galderma Labs Lp.
Clobex contains Clobetasol Propionate.
Clobex has a total of 3 drug patents out of which 3 drug patents have expired.
Expired drug patents of Clobex are:
- US6106848
- US5972920
- US5990100
Clobex was authorised for market use on 24 July, 2003.
Clobex is available in spray;topical dosage forms.
Clobex can be used as twice daily topical treatment of moderate to severe plaque psoriasis..
The generics of Clobex are possible to be released after 24 March, 2018.
Drugs and Companies using CLOBETASOL PROPIONATE ingredient
Market Authorisation Date: 24 July, 2003
Treatment: Twice daily topical treatment of moderate to severe plaque psoriasis.
Dosage: SPRAY;TOPICAL
CLOBEX family patents
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8066975 | GALDERMA LABS | Foaming composition for washing and treating hair and/or scalp based on an active principle |
Jun, 2019
(4 years ago) | |
| US7316810 | GALDERMA LABS | Foaming composition for washing and treating hair and/or scalp based on an active principle |
Jun, 2019
(4 years ago) | |
| US8066976 | GALDERMA LABS | Foaming compositions for hair care |
Jun, 2019
(4 years ago) | |
| US7700081 | GALDERMA LABS | Foaming compositions for hair care |
Jan, 2022
(2 years ago) | |
Clobex is owned by Galderma Labs.
Clobex contains Clobetasol Propionate.
Clobex has a total of 4 drug patents out of which 4 drug patents have expired.
Expired drug patents of Clobex are:
- US8066975
- US7316810
- US8066976
- US7700081
Clobex was authorised for market use on 05 February, 2004.
Clobex is available in shampoo;topical dosage forms.
Clobex can be used as topical treatment of scalp psoriasis.
The generics of Clobex are possible to be released after 03 January, 2022.
Drugs and Companies using CLOBETASOL PROPIONATE ingredient
Market Authorisation Date: 05 February, 2004
Treatment: Topical treatment of scalp psoriasis
Dosage: SHAMPOO;TOPICAL
CLOBEX family patents